Nachrichten zur Amgen Inc. Aktie

Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?

2024 was an excellent year for the major stock market indexes. But the Dow Jones Industrial Average (DJINDICES: ^DJI) had…

Amgen: Likely To Be Rangebound (Rating Downgrade)

…

Amgens Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer

The FDA approves Amgens Lumakras in combination with Vectibix for treating previously treated adults with KRAS G12C-mutated metastatic colorectal cancer.…

Amgen Aktie: Starkes Wachstum sichert Zukunft

Die Amgen Aktie zeigt sich zum Jahresstart 2025 in robuster Verfassung. Der Biotechnologie-Konzern verzeichnete am 18. Januar einen Kursanstieg von…

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this…

Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.

A $5,000 investment can go a long way, especially if youre loading up on fairly cheap stocks that may possess…

Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

…

3 High-Yield Dividend Stocks to Buy in 2025

High-yield dividend stocks may not appeal to some investors. However, if youre among those investors looking for income, stocks that…

Amgen Aktie: Softwaremarkt bleibt herausfordernd

San Francisco (www.aktiencheck.de) - Adobe-Aktienanalyse von Wells Fargo Advisors: Rating und Kursziel Wells Fargo hat das Kursziel für Amgen Inc. (ISIN: US0311621009,…

Amgen Aktie: Solide Q4-Ergebnisse erwartet - Neues Kursziel

Toronto (www.aktiencheck.de) - Amgen-Aktienanalyse von RBC Capital Markets: Rating und Kursziel RBC Capital hat das Kursziel für Amgen Inc. (ISIN: US0311621009, WKN:…

Amgen Aktie: Kursziel gesenkt - Hoher Wettbewerb dämpft Wachstumsperspektiven

Charlotte, NC (www.aktiencheck.de) - Amgen-Aktienanalyse von Truist: Rating und Kursziel Truist hat das Kursziel für Amgen Inc. (ISIN: US0311621009, WKN: 867900, Ticker-Symbol:…

The Zacks Analyst Blog Highlights Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR

Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR are part of the Zacks top Analyst Blog.…

Amgen: Blockbusters, Emerging Therapies, And Investment Potential

…

Top Analyst Reports for Microsoft, Exxon Mobil & Amgen

Todays Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Exxon Mobil Corporation (XOM) and…

Prediction: These 3 Healthcare Stocks Will Soar in 2025

No one knows for sure what the new year will hold for the market. However, some stocks chances for success…

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

The Dow Jones Industrial Average contains 30 handpicked companies that are, or at least once were, leaders in their respective…

Neue 7,75% Aktienanleihe mit Barriere Quanto auf Amgen in Zeichnung

München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VG016W8/ WKN VG016W)…

1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of…

Amgen Aktie: Herausforderungen durch Verlust von Exklusivitäten

Minneapolis (www.aktiencheck.de) - Amgen-Aktienanalyse von Piper Sandler: Aktuelle Bewertung Piper Sandler hat das Kursziel für die Aktie von Amgen Inc. (ISIN: US0311621009,…

2 Excellent Dividend Stocks to Buy on the Dip

AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN) have a lot in common. They are both leading drugmakers and have strong…

Now That Nvidia and Amazon Are in the Dow Jones, Can the Index Beat the S&P 500 and Nasdaq in 2025?

The historic Dow Jones Industrial Average (DJINDICES: ^DJI) has undergone major changes in recent years. In 2020, Salesforce (NYSE: CRM),…

These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over

Its been a banner year for the stock market. However, not every stock has been a winner as some sectors…

Amgen Aktie: BofA nimmt Coverage wieder auf - Herausforderungen durch Patentausläufe

Charlotte (www.aktiencheck.de) - Amgen-Aktienanalyse von BofA Securities: Rating und Kursziel BofA-Analyst Tim Anderson hat die Coverage der Aktie von Amgen Inc. (ISIN:…

Is Coca-Cola Stock a Buy, Sell, or Hold in 2025?

Coca-Cola (NYSE: KO) will likely be selling many more beverages in a few years than it did in 2024. Theres…

2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer

Whether youre looking for a way to beat the benchmark S&P 500 index or you just want a steady flow…

Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Heres What It Says.

Eli Lilly (NYSE: LLY) has produced a wide variety of treatments for various illnesses throughout its 145-year history. But this…

California biotech company, Amgen, investing $1 billion in Wake County, creating more than 300 jobs

Amgens agreement with the state could also move more than $1 million into a fund that helps rural communities.…

Hundreds of jobs coming to Wake County with Biotech company Amgens expansion in Holly Springs

Amgens agreement with the state could also move more than $1 million into a fund that helps rural communities.…

Is Amgen Still a Top Dividend Stock?

The relationship between interest rates and dividend stocks tends to follow a predictable pattern. When the Federal Reserve signals a…

Amgen Inc. (AMGN) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)

…

Eli Lilly Just Got a Bundle of Good News: Time to Buy?

The magic isnt over for Eli Lilly (NYSE: LLY). Though the pharmaceutical giant isnt performing as well in the second…

Top Stock Reports for Amgen, Eaton & Enzo Biochem

Todays Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Eaton Corp. plc (ETN) and…

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?

Theres a growing number of companies entering the weight loss space, focusing on GLP-1 drugs which can be game changers…

This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip?

The biotech industry can be volatile even for relatively large companies. Amgen (NASDAQ: AMGN), one of the more prominent names…

Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?

The market didnt appreciate Amgens (NASDAQ: AMGN) latest clinical data update, with the biopharmas shares falling more than 12% at…

Is Novo Nordisk Stock a Buy?

Few companies garner as much reliable attention as Novo Nordisk (NYSE: NVO) does these days. With a bull market coinciding…

Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?

Shares of Amgen (NASDAQ: AMGN) are down by 6% in the last 30 days as I write this -- a…

Novo Nordisk nach der Korrektur: Doppelte Kaufempfehlung

Die Aktie des dänischen Biopharmakonzerns Novo Nordisk hat sich in den vergangenen Tagen deutlich von ihren jüngsten Tiefs lösen können.…

Amgens Phase 2 Results Were Not Bad, Dont Let Mr. Market Fool You

…

Amgen Aktie bleibt attraktiv trotz Herausforderungen bei MariTide

Toronto (www.aktiencheck.de) - Amgen-Aktienanalyse von RBC Capital Markets: Aktuelle Bewertung Gregory Renza von RBC Capital hat das Kursziel für Amgen Inc. (ISIN:…

Deutsche Bank Research belässt Novo Nordisk auf Buy

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Novo Nordisk mit einem Kursziel von 1000 dänischen Kronen…

Amgen: Checks All The Wrong Boxes

…

Why Amgens Weight Loss Result Is a Win for Eli Lilly

Shares of Amgen (NASDAQ: AMGN) recently ticked lower despite a very positive-sounding press release regarding its weight management candidate. According…

Amgen Aktie unter Druck - Gewichtsdaten enttäuschen

Frankfurt (www.aktiencheck.de) - Amgen-Aktienanalyse von Deutsche Bank: Rating und Kursziel Deutsche Bank bewertet die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900,…

Nach Amgen-Enttäuschung: Novo Nordisk, Eli Lilly & Co unter der Lupe

Die Aktie von Amgen hat am Dienstag einen kräftigen Rücksetzer erlitten. Auslöser waren Daten zum Adipositas-Hoffnungsträger MariTide, die schlechter als…

Märkte am Morgen: DAX auf Richtungssuche; Bitcoin, Daimler Truck, Amgen, General Motors, Deere, Dell, LOréal, Amazon, Intel

Der DAX hat gestern nicht an die Gewinne vom Montag anknüpfen können. Letzten Endes rutschte er wieder unter 19.300 Punkte.…

dpa-AFX ProFeed